These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 35681583)
21. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Atretkhany KN; Mufazalov IA; Dunst J; Kuchmiy A; Gogoleva VS; Andruszewski D; Drutskaya MS; Faustman DL; Schwabenland M; Prinz M; Kruglov AA; Waisman A; Nedospasov SA Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13051-13056. PubMed ID: 30498033 [TBL] [Abstract][Full Text] [Related]
22. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4 Chen S; Li R; Chen Y; Chou CK; Zhang Z; Yang Y; Liao P; Wang Q; Chen X Biomed Pharmacother; 2022 Jul; 151():113187. PubMed ID: 35676787 [TBL] [Abstract][Full Text] [Related]
23. TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine. Faustman DL; Davis M Front Immunol; 2013 Dec; 4():478. PubMed ID: 24391650 [TBL] [Abstract][Full Text] [Related]
24. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis. Ye LL; Peng WB; Niu YR; Xiang X; Wei XS; Wang ZH; Wang X; Zhang SY; Chen X; Zhou Q Ann Transl Med; 2020 Dec; 8(24):1647. PubMed ID: 33490159 [TBL] [Abstract][Full Text] [Related]
25. Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer. Wajant H; Beilhack A Front Immunol; 2019; 10():2040. PubMed ID: 31555271 [TBL] [Abstract][Full Text] [Related]
26. Aberrant frequency of TNFR2 Zhang T; Jiao J; Jiao X; Zhao L; Tian X; Zhang Q; Ma D; Cui B Oncotarget; 2018 Jan; 9(4):5073-5083. PubMed ID: 29435163 [TBL] [Abstract][Full Text] [Related]
27. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy. Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151 [TBL] [Abstract][Full Text] [Related]
28. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426 [TBL] [Abstract][Full Text] [Related]
29. The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment. Mohd Salim NH; Mussa A; Ahmed N; Ahmad S; Yean Yean C; Hassan R; Uskoković V; Mohamud R; Che Jalil NA Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672682 [TBL] [Abstract][Full Text] [Related]
30. TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2. Cabal-Hierro L; Rodríguez M; Artime N; Iglesias J; Ugarte L; Prado MA; Lazo PS Cell Signal; 2014 Dec; 26(12):2658-66. PubMed ID: 25152365 [TBL] [Abstract][Full Text] [Related]
31. Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4⁺ Foxp3⁺ regulatory T cells. Hu Y; Xiao H; Shi T; Oppenheim JJ; Chen X Immunology; 2014 Jun; 142(2):193-201. PubMed ID: 24383743 [TBL] [Abstract][Full Text] [Related]
32. TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages. Wajant H; Siegmund D Front Cell Dev Biol; 2019; 7():91. PubMed ID: 31192209 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic potential of TNFR2 agonists: a mechanistic perspective. Chen Y; Jiang M; Chen X Front Immunol; 2023; 14():1209188. PubMed ID: 37662935 [TBL] [Abstract][Full Text] [Related]
34. Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Nie Y; He J; Shirota H; Trivett AL; Yang D; Klinman DM; Oppenheim JJ; Chen X Sci Signal; 2018 Jan; 11(511):. PubMed ID: 29295954 [TBL] [Abstract][Full Text] [Related]
35. Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer's Disease. Ortí-Casañ N; Wu Y; Naudé PJW; De Deyn PP; Zuhorn IS; Eisel ULM Front Neurosci; 2019; 13():49. PubMed ID: 30778285 [TBL] [Abstract][Full Text] [Related]
36. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents. Zou H; Li R; Hu H; Hu Y; Chen X Front Immunol; 2018; 9():594. PubMed ID: 29632537 [TBL] [Abstract][Full Text] [Related]
37. Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis. Siegmund D; Kums J; Ehrenschwender M; Wajant H Cell Death Dis; 2016 Sep; 7(9):e2375. PubMed ID: 27899821 [TBL] [Abstract][Full Text] [Related]
38. The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. Till A; Rosenstiel P; Krippner-Heidenreich A; Mascheretti-Croucher S; Croucher PJ; Schäfer H; Scheurich P; Seegert D; Schreiber S J Biol Chem; 2005 Feb; 280(7):5994-6004. PubMed ID: 15572357 [TBL] [Abstract][Full Text] [Related]
39. TNF receptor 2 signaling prevents DNA methylation at the Tseng WY; Huang YS; Clanchy F; McNamee K; Perocheau D; Ogbechi J; Luo SF; Feldmann M; McCann FE; Williams RO Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21666-21672. PubMed ID: 31597740 [TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1. Chopra M; Lang I; Salzmann S; Pachel C; Kraus S; Bäuerlein CA; Brede C; Garrote AL; Mattenheimer K; Ritz M; Schwinn S; Graf C; Schäfer V; Frantz S; Einsele H; Wajant H; Beilhack A PLoS One; 2013; 8(9):e75737. PubMed ID: 24098720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]